{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:18:49Z","timestamp":1787044729673,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["733050509"],"award-info":[{"award-number":["733050509"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The DEmEntia with LEwy bOdies Project (DEvELOP) aims to phenotype patients with dementia with Lewy bodies (DLB) and study the symptoms and biomarkers over time. Here, we describe the design and baseline results of DEvELOP. We investigated the associations between core and suggestive DLB symptoms and different aspects of disease burden, i.e., instrumental activities of daily living (IADL) functioning, quality of life (QoL), and caregiver burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We included 100 DLB patients (69\u2009\u00b1\u20096\u2009years, 10%F, MMSE 25\u2009\u00b1\u20093) in the prospective DEvELOP cohort. Patients underwent extensive assessment including MRI, EEG\/MEG,\n                      <jats:sup>123<\/jats:sup>\n                      FP-CIT SPECT, and CSF and blood collection, with annual follow-up. Core (hallucinations, parkinsonism, fluctuations, RBD) and suggestive (autonomous dysfunction, neuropsychiatric symptoms) symptoms were assessed using standardized questionnaires. We used multivariate regression analyses, adjusted for age, sex, and MMSE, to evaluate how symptoms related to the Functional Activities Questionnaire, QoL-AD questionnaire, and Zarit Caregiver Burden Interview.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In our cohort, RBD was the most frequently reported core feature (75%), while visual hallucinations were least frequently reported (39%) and caused minimal distress. Suggestive clinical features were commonly present, of which orthostatic hypotension was most frequently reported (64%). Ninety-five percent of patients showed EEG\/MEG abnormalities, 88% of\n                      <jats:sup>123<\/jats:sup>\n                      FP-CIT SPECT scans were abnormal, and 53% had a CSF Alzheimer\u2019s disease profile. Presence of fluctuations, lower MMSE, parkinsonism, and apathy were associated with higher IADL dependency. Depression, constipation, and lower IADL were associated with lower QoL-AD. Apathy and higher IADL dependency predisposed for higher caregiver burden.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Baseline data of our prospective DLB cohort show clinically relevant associations between symptomatology and disease burden. Cognitive and motor symptoms are related to IADL functioning, while negative neuropsychiatric symptoms and functional dependency are important determinants of QoL and caregiver burden. Follow-up is currently ongoing to address specific gaps in DLB research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00792-w","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T03:04:32Z","timestamp":1614308672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results"],"prefix":"10.1186","volume":"13","author":[{"given":"M.","family":"van de Beek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"van Steenoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"van der Zande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Porcelijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. G. H. M.","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. M.","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. W.","family":"Lemstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"issue":"4","key":"792_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SV Jones","year":"2014","unstructured":"Jones SV, O\u2019Brien J. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44(4):673\u201383.","journal-title":"Psychol Med"},{"issue":"1","key":"792_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","volume":"10","author":"JP Kane","year":"2018","unstructured":"Kane JP, Surendranathan A, Bentley A, Barker SA, Taylor J-P, Thomas AJ, et al. Clinical prevalence of Lewy body dementia. Alzheimers Res Ther. 2018;10(1):19.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"792_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100.","journal-title":"Neurology."},{"issue":"2","key":"792_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/WAD.0b013e318065c4a9","volume":"21","author":"F Bostr\u00f6m","year":"2007","unstructured":"Bostr\u00f6m F, J\u00f6nsson L, Minthon L, Londos E. Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2007;21(2):150\u20134.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"792_CR5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-190041","volume":"70","author":"M van de Beek","year":"2019","unstructured":"van de Beek M, van Steenoven I, Ramakers IH, Aalten P, Koek HL, Rikkert O, et al. Trajectories and determinants of quality of life in dementia with Lewy bodies and Alzheimer\u2019s disease. J Alzheimers Dis. 2019;70(2):387\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"792_CR6","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.archger.2008.10.001","volume":"49","author":"M Ricci","year":"2009","unstructured":"Ricci M, Guidoni SV, Sepe-Monti M, Bomboi G, Antonini G, Blundo C, et al. Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer\u2019s disease (AD). Arch Gerontol Geriatr. 2009;49(2):e101\u20134.","journal-title":"Arch Gerontol Geriatr"},{"issue":"9","key":"792_CR7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/gps.4433","volume":"31","author":"E Svendsboe","year":"2016","unstructured":"Svendsboe E, Terum T, Testad I, Aarsland D, Ulstein I, Corbett A, et al. Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2016;31(9):1075\u201383.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"792_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/alzrt251","volume":"6","author":"YR Zweig","year":"2014","unstructured":"Zweig YR, Galvin JE. Lewy body dementia: the impact on patients and caregivers. Alzheimers Res Ther. 2014;6(2):21.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"792_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"J-P Taylor","year":"2020","unstructured":"Taylor J-P, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19(2):157\u201369.","journal-title":"Lancet Neurol."},{"issue":"3","key":"792_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3233\/JAD-170850","volume":"62","author":"WM van der Flier","year":"2018","unstructured":"van der Flier WM, Scheltens P. Amsterdam dementia cohort: performing research to optimize care. J Alzheimers Dis. 2018;62(3):1091\u2013111.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"792_CR11","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"I McKeith","year":"2005","unstructured":"McKeith I, Dickson DW, Lowe J, Emre M, O\u2019brien J, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies third report of the DLB Consortium. Neurology. 2005;65(12):1863\u201372.","journal-title":"Neurology."},{"key":"792_CR12","doi-asserted-by":"crossref","unstructured":"van de Beek M, van Steenoven I, van der Zande JJ, Barkhof F, Teunissen CE, van der Flier WM, Lemstra AW. Prodromal dementia with lewy bodies: clinical characterization and predictors of progression. Mov Disord. 2020;35(5):859\u201367.","DOI":"10.1002\/mds.27997"},{"issue":"3","key":"792_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"issue":"17","key":"792_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743\u201355.","journal-title":"Neurology."},{"key":"792_CR15","unstructured":"JPND Working Group on Longitudinal Cohorts: Multi-centre cohort-studies in Lewy-body dementia: challenges in harmonizing different clinical and biomarker protocols 2015 [Available from: https:\/\/www.neurodegenerationresearch.eu\/wp-content\/uploads\/2015\/10\/JPND-Report-Aarsland.pdf."},{"issue":"2","key":"792_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jnnp.73.2.126","volume":"73","author":"J Lindeboom","year":"2002","unstructured":"Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C. Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry. 2002;73(2):126\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"792_CR17","volume-title":"De 15-woordentest A en B (een voorlopige handleiding)","author":"R Saan","year":"1986","unstructured":"Saan R, Deelman B. De 15-woordentest A en B (een voorlopige handleiding). Groningen: Afdeling Neuropsychologie, AZG; 1986."},{"issue":"1","key":"792_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1037\/0096-3445.121.1.15","volume":"121","author":"JR Stroop","year":"1992","unstructured":"Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol Gen. 1992;121(1):15.","journal-title":"J Exp Psychol Gen"},{"issue":"3","key":"792_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8(3):271\u20136.","journal-title":"Percept Mot Skills"},{"issue":"2","key":"792_CR20","first-page":"63","volume":"25","author":"J Lindeboom","year":"1994","unstructured":"Lindeboom J, Matto D. Digit series and Knox cubes as concentration tests for elderly subjects. Tijdschr Gerontol Geriatr. 1994;25(2):63\u20138.","journal-title":"Tijdschr Gerontol Geriatr"},{"issue":"1","key":"792_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1017\/S1355617706060115","volume":"12","author":"W Van Der Elst","year":"2006","unstructured":"Van Der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. Normative data for the animal, profession and letter M naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc. 2006;12(1):80\u20139.","journal-title":"J Int Neuropsychol Soc"},{"issue":"11","key":"792_CR22","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11):1621\u20136.","journal-title":"Neurology."},{"key":"792_CR23","volume-title":"The visual object and space perception battery","author":"E Warrington","year":"1991","unstructured":"Warrington E, James M. The visual object and space perception battery, vol. 2015. Bury St. Edmunds (UK): Thames Valley Test; 1991."},{"issue":"15","key":"792_CR24","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129\u201370.","journal-title":"Mov Disord"},{"issue":"5","key":"792_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427.","journal-title":"Neurology"},{"issue":"5","key":"792_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.sleep.2010.12.009","volume":"12","author":"BF Boeve","year":"2011","unstructured":"Boeve BF, Molano JR, Ferman TJ, Smith GE, Lin S-C, Bieniek K, et al. Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. Sleep Med. 2011;12(5):445\u201353.","journal-title":"Sleep Med"},{"issue":"3","key":"792_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1192\/bjp.177.3.252","volume":"177","author":"M Walker","year":"2000","unstructured":"Walker M, Ayre G, Cummings J, Wesnes K, McKeith I, O\u2019Brien J, et al. The clinician assessment of fluctuation and the one day fluctuation assessment scale: two methods to assess fluctuating confusion in dementia. Br J Psychiatry. 2000;177(3):252\u20136.","journal-title":"Br J Psychiatry"},{"issue":"6","key":"792_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archneur.58.6.977","volume":"58","author":"C Ballard","year":"2001","unstructured":"Ballard C, O\u2019Brien J, Gray A, Cormack F, Ayre G, Rowan E, et al. Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol. 2001;58(6):977\u201382.","journal-title":"Arch Neurol"},{"issue":"Supplement_1","key":"792_CR29","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1093\/schbul\/sby148","volume":"45","author":"SL Rossell","year":"2019","unstructured":"Rossell SL, Schutte MJ, Toh WL, Thomas N, Strauss C, Linszen MM, et al. The questionnaire for psychotic experiences: an examination of the validity and reliability. Schizophr Bull. 2019;45(Supplement_1):S78\u201387.","journal-title":"Schizophr Bull"},{"key":"792_CR30","doi-asserted-by":"crossref","unstructured":"Yesavage JA, Sheikh JI. 9\/Geriatric depression scale (GDS) recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1-2):165\u201373","DOI":"10.1300\/J018v05n01_09"},{"issue":"5 Suppl 6","key":"792_CR31","doi-asserted-by":"publisher","first-page":"10S","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","volume":"48","author":"JL Cummings","year":"1997","unstructured":"Cummings JL. The Neuropsychiatric Inventory assessing psychopathology in dementia patients. Neurology. 1997;48(5 Suppl 6):10S\u20136S.","journal-title":"Neurology."},{"key":"792_CR32","doi-asserted-by":"crossref","unstructured":"Kleipool EE, Trappenburg MC, Rhodius-Meester HF, Lemstra AW, van der Flier WM, Peters MJ, Muller M. Orthostatic hypotension: an important risk factor for clinical progression to mild cognitive impairment or dementia. The Amsterdam dementia cohort. J Alzheimers Dis. 2019;71(1):317\u201325.","DOI":"10.3233\/JAD-190402"},{"issue":"13","key":"792_CR33","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: results from an international pilot study. Mov Disord. 2007;22(13):1901\u201311.","journal-title":"Mov Disord"},{"issue":"3","key":"792_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah C Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323\u20139.","journal-title":"J Gerontol"},{"key":"792_CR35","first-page":"21","volume":"5","author":"RG Logsdon","year":"1999","unstructured":"Logsdon RG, Gibbons LE, McCurry SM, Teri L. Quality of life in Alzheimer\u2019s disease: patient and caregiver reports. J Ment Health Aging. 1999;5:21\u201332.","journal-title":"J Ment Health Aging"},{"issue":"6","key":"792_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. The Gerontologist. 1980;20(6):649\u201355.","journal-title":"The Gerontologist"},{"issue":"22","key":"792_CR37","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"C Teunissen","year":"2009","unstructured":"Teunissen C, Petzold A, Bennett J, Berven F, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73(22):1914\u201322.","journal-title":"Neurology."},{"key":"792_CR38","doi-asserted-by":"crossref","unstructured":"Tijms BM, Willemse EA, Zwan MD, Mulder SD, Visser PJ, van Berckel BN, et al. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-\u03b2 1\u201342 analysis results. Clin Chem. 2017; clinchem. 2017.281055.","DOI":"10.1373\/clinchem.2017.281055"},{"key":"792_CR39","doi-asserted-by":"crossref","unstructured":"Willemse EA, Tijms BM, Van Berckel BN, Gannon S, Le Bastard N, Latham J, Teunissen CE. Using cerebrospinal fluid amyloidbeta (1\u201042) in the memory clinic: Concordance with PET and use of biomarker ratios across immunoassays: Biomarkers (non\u2010neuroimaging): Method development and validation. Alzheimers Dement 2020;16:e045128.","DOI":"10.1002\/alz.045128"},{"issue":"10","key":"792_CR40","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein H, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"792_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000117417","volume":"37","author":"P Scheltens","year":"1997","unstructured":"Scheltens P, Pasquier F, Weerts JG, Barkhof F, Leys D. Qualitative assessment of cerebral atrophy on MRI: inter-and intra-observer reproducibility in dementia and normal aging. Eur Neurol. 1997;37(2):95\u20139.","journal-title":"Eur Neurol"},{"issue":"12","key":"792_CR42","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","volume":"21","author":"EL Koedam","year":"2011","unstructured":"Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21(12):2618\u201325.","journal-title":"Eur Radiol"},{"issue":"2","key":"792_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149(2):351\u20136.","journal-title":"Am J Roentgenol"},{"issue":"9","key":"792_CR44","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/01.wnl.0000210535.20297.ae","volume":"66","author":"C Cordonnier","year":"2006","unstructured":"Cordonnier C, Van der Flier W, Sluimer J, Leys D, Barkhof F, Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology. 2006;66(9):1356\u201360.","journal-title":"Neurology."},{"issue":"1","key":"792_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000182422","volume":"27","author":"M Liedorp","year":"2009","unstructured":"Liedorp M, Van Der Flier W, Hoogervorst E, Scheltens P, Stam C. Associations between patterns of EEG abnormalities and diagnosis in a large memory clinic cohort. Dement Geriatr Cogn Disord. 2009;27(1):18\u201323.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"792_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/brain\/awn262","volume":"132","author":"C Stam","year":"2009","unstructured":"Stam C, De Haan W, Daffertshofer A, Jones B, Manshanden I, van Cappellen van Walsum A-M, et al. Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer\u2019s disease. Brain. 2009;132(1):213\u201324.","journal-title":"Brain."},{"issue":"2","key":"792_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2012-304811","volume":"85","author":"C Vriend","year":"2014","unstructured":"Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, et al. Depressive symptoms in Parkinson\u2019s disease are related to reduced [123I] FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry. 2014;85(2):159\u201364.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"792_CR48","volume-title":"R: a language and environment for statistical computing. 4.0.2 ed","author":"Team. RC. R Core Team","year":"2020","unstructured":"Team. RC. R Core Team. R: a language and environment for statistical computing. 4.0.2 ed. 2020."},{"issue":"2","key":"792_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","volume":"88","author":"AW Lemstra","year":"2017","unstructured":"Lemstra AW, de Beer MH, Teunissen CE, Schreuder C, Scheltens P, van der Flier WM, et al. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2017;88(2):113\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"792_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/JAD-160322","volume":"54","author":"I van Steenoven","year":"2016","unstructured":"van Steenoven I, Aarsland D, Weintraub D, Londos E, Blanc F, van der Flier WM, et al. Cerebrospinal fluid Alzheimer\u2019s disease biomarkers across the spectrum of Lewy body diseases: results from a large multicenter cohort. J Alzheimers Dis. 2016;54(1):287\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"792_CR51","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","volume":"60","author":"A Merdes","year":"2003","unstructured":"Merdes A, Hansen L, Jeste D, Galasko D, Hofstetter C, Ho G, et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 2003;60(10):1586\u201390.","journal-title":"Neurology."},{"issue":"5","key":"792_CR52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","volume":"20","author":"BN Dugger","year":"2014","unstructured":"Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, et al. Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord. 2014;20(5):525\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"792_CR53","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska Z, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Murray ME, et al. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging. 2015;36(1):452\u201361.","journal-title":"Neurobiol Aging"},{"issue":"10004","key":"792_CR54","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet. 2015;386(10004):1683\u201397.","journal-title":"Lancet"},{"issue":"9","key":"792_CR55","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0b013e31822c9148","volume":"77","author":"TJ Ferman","year":"2011","unstructured":"Ferman TJ, Boeve BF, Smith G, Lin S-C, Silber M, Pedraza O, et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011;77(9):875\u201382.","journal-title":"Neurology."},{"issue":"4","key":"792_CR56","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3233\/JAD-160385","volume":"55","author":"A Cagnin","year":"2017","unstructured":"Cagnin A, Fragiacomo F, Camporese G, Turco M, Buss\u00e8 C, Ermani M, et al. Sleep-wake profile in dementia with Lewy bodies, Alzheimer\u2019s disease, and normal aging. J Alzheimers Dis. 2017;55(4):1529\u201336.","journal-title":"J Alzheimers Dis"},{"issue":"14","key":"792_CR57","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1017\/S0033291718003161","volume":"49","author":"CL Eversfield","year":"2019","unstructured":"Eversfield CL, Orton LD. Auditory and visual hallucination prevalence in Parkinson\u2019s disease and dementia with Lewy bodies: a systematic review and meta-analysis. Psychol Med. 2019;49(14):2342\u201353.","journal-title":"Psychol Med"},{"issue":"2","key":"792_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/01.JGP.0000192480.89813.80","volume":"14","author":"UP Mosimann","year":"2006","unstructured":"Mosimann UP, Rowan EN, Partington CE, Collerton D, Littlewood E, O\u2019Brien JT, et al. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. Am J Geriatr Psychiatry. 2006;14(2):153\u201360.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"792_CR59","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","volume":"16","author":"C Mueller","year":"2017","unstructured":"Mueller C, Ballard C, Corbett A, Aarsland D. The prognosis of dementia with Lewy bodies. Lancet Neurol. 2017;16(5):390\u20138.","journal-title":"Lancet Neurol"},{"key":"792_CR60","first-page":"143","volume":"10","author":"C Mueller","year":"2018","unstructured":"Mueller C, Perera G, Rajkumar AP, Bhattarai M, Price A, O\u2019Brien JT, et al. Hospitalization in people with dementia with Lewy bodies: frequency, duration, and cost implications. Alzheimers Dement Diagn Assess Dis Monit. 2018;10:143\u201352.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"2","key":"792_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jalz.2013.04.003","volume":"10","author":"JM Hamilton","year":"2014","unstructured":"Hamilton JM, Salmon DP, Raman R, Hansen LA, Masliah E, Peavy GM, et al. Accounting for functional loss in Alzheimer\u2019s disease and dementia with Lewy bodies: beyond cognition. Alzheimers Dement. 2014;10(2):171\u20138.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"792_CR62","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1002\/gps.4788","volume":"33","author":"M Sun","year":"2018","unstructured":"Sun M, Mainland BJ, Ornstein TJ, Mallya S, Fiocco AJ, Sin GL, et al. The association between cognitive fluctuations and activities of daily living and quality of life among institutionalized patients with dementia. Int J Geriatr Psychiatry. 2018;33(2):e280\u2013e5.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"792_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/geront\/gnq055","volume":"51","author":"AN Leggett","year":"2010","unstructured":"Leggett AN, Zarit S, Taylor A, Galvin JE. Stress and burden among caregivers of patients with Lewy body dementia. The Gerontologist. 2010;51(1):76\u201385.","journal-title":"The Gerontologist"},{"issue":"1","key":"792_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/gps.2494","volume":"26","author":"R Trigg","year":"2011","unstructured":"Trigg R, Watts S, Jones R, Tod A. Predictors of quality of life ratings from persons with dementia: the role of insight. Int J Geriatr Psychiatry. 2011;26(1):83\u201391.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"2","key":"792_CR65","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/gps.3799","volume":"28","author":"DR Lee","year":"2013","unstructured":"Lee DR, McKeith I, Mosimann U, Ghosh-Nodyal A, Thomas AJ. Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. Int J Geriatr Psychiatry. 2013;28(2):135\u201341.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"8","key":"792_CR66","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1017\/S1041610217002630","volume":"30","author":"S Liu","year":"2018","unstructured":"Liu S, Liu J, Xiao-Dan W, Shi Z, Zhou Y, Li J, et al. Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer\u2019s disease. Int Psychogeriatr. 2018;30(8):1131\u20138.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"792_CR67","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JAD-131337","volume":"39","author":"R Perri","year":"2014","unstructured":"Perri R, Monaco M, Fadda L, Caltagirone C, Carlesimo GA. Neuropsychological correlates of behavioral symptoms in Alzheimer\u2019s disease, frontal variant of frontotemporal, subcortical vascular, and Lewy body dementias: a comparative study. J Alzheimers Dis. 2014;39(3):669\u201377.","journal-title":"J Alzheimers Dis"},{"key":"792_CR68","doi-asserted-by":"crossref","unstructured":"Donaghy PC, Ciafone J, Durcan R, Hamilton CA, Barker S, Lloyd J, et al. Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile. Psychol Med. 2020:1-9.","DOI":"10.1017\/S0033291720002901"},{"key":"792_CR69","doi-asserted-by":"crossref","unstructured":"Donaghy PC, Taylor JP, O\u2019Brien JT, Barnett N, Olsen K, Colloby SJ, et al. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies. Psychol Med. 2018;48(14):2384-90.\u00a0","DOI":"10.1017\/S0033291717003956"},{"key":"792_CR70","doi-asserted-by":"crossref","unstructured":"Connors MH, Quinto L, McKeith I, Brodaty H, Allan L, Bamford C, et al. Non-pharmacological interventions for Lewy body dementia: a systematic review. Psychol Med. 2018;48(11):1749-58.\u00a0","DOI":"10.1017\/S0033291717003257"},{"issue":"4","key":"792_CR71","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1192\/bjp.bp.114.148130","volume":"207","author":"V Orgeta","year":"2015","unstructured":"Orgeta V, Qazi A, Spector A, Orrell M. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis. Br J Psychiatry. 2015;207(4):293\u20138.","journal-title":"Br J Psychiatry"},{"issue":"6","key":"792_CR72","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/YCO.0b013e32834bb9d4","volume":"24","author":"D Enache","year":"2011","unstructured":"Enache D, Winblad B, Aarsland D. Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry. 2011;24(6):461\u201372.","journal-title":"Curr Opin Psychiatry"},{"issue":"8","key":"792_CR73","doi-asserted-by":"publisher","first-page":"810","DOI":"10.4088\/JCP.12m08099","volume":"74","author":"PB Rosenberg","year":"2013","unstructured":"Rosenberg PB, Lanct\u00f4t KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, et al. Safety and efficacy of methylphenidate for apathy in Alzheimer\u2019s disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013;74(8):810.","journal-title":"J Clin Psychiatry"},{"key":"792_CR74","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.parkreldis.2018.11.002","volume":"60","author":"J Liu","year":"2019","unstructured":"Liu J, Cooper CA, Weintraub D, Dahodwala N. Pharmacological treatment of apathy in Lewy body disorders: a systematic review. Parkinsonism Relat Disord. 2019;60:14\u201324.","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"792_CR75","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40266-013-0092-x","volume":"30","author":"C Ballard","year":"2013","unstructured":"Ballard C, Aarsland D, Francis P, Corbett A. Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management. Drugs Aging. 2013;30(8):603\u201311.","journal-title":"Drugs Aging"},{"key":"792_CR76","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2147\/NDT.S45840","volume":"9","author":"S-M Fereshtehnejad","year":"2013","unstructured":"Fereshtehnejad S-M, Religa D, Westman E, Aarsland D, L\u00f6kk J, Eriksdotter M. Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson\u2019s disease with dementia: data from the Swedish Dementia Quality Registry (SveDem). Neuropsychiatr Dis Treat. 2013;9:927.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"792_CR77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13195-020-00610-9","volume":"12","author":"M van de Beek","year":"2020","unstructured":"van de Beek M, Babapour Mofrad R, van Steenoven I, Vanderstichele H, Scheltens P, Teunissen CE, et al. Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies. Alzheimers Res Ther. 2020;12(1):44.","journal-title":"Alzheimers Res Ther"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00792-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-021-00792-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00792-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T03:05:07Z","timestamp":1614308707000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00792-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00792-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The local medical ethics committee approved the study, and patients and caregivers gave their written informed consent. The research is performed according to the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MvdB, IvS, JvdZ, IP, CS, and PR report no competing interests relevant to the manuscript. FB is supported by the NIHR Biomedical Research Centre at UCLH. CT is a member of the Innogenetics International Advisory Boards of Fujirebio\/Innogenetics and Roche. PS has served as a consultant for Wyeth-Elan, Genentech, Danone, and Novartis and received funding for travel from Pfizer, Elan, Janssen, and Danone Research. WvdF performs the contract research for Boehringer Ingelheim. Her research programs have been funded by ZonMW, NWO, EU-FP7, Alzheimer Nederland, CardioVascular Onderzoek Nederland, Stichting Dioraphte, Gieskes-Strijbis fonds, Boehringer Ingelheim, Piramal Neuroimaging, Roche BV, and Janssen Stellar. All funding is paid to her institution. AL has received funding from Stichting Dioraphte and ZonMW Memorabel (project #733050509).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}